These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 30675854)
1. The Controlled Human Malaria Infection Experience at the University of Maryland. Friedman-Klabanoff DJ; Laurens MB; Berry AA; Travassos MA; Adams M; Strauss KA; Shrestha B; Levine MM; Edelman R; Lyke KE Am J Trop Med Hyg; 2019 Mar; 100(3):556-565. PubMed ID: 30675854 [TBL] [Abstract][Full Text] [Related]
2. Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity rates. Gómez-Pérez GP; Legarda A; Muñoz J; Sim BK; Ballester MR; Dobaño C; Moncunill G; Campo JJ; Cisteró P; Jimenez A; Barrios D; Mordmüller B; Pardos J; Navarro M; Zita CJ; Nhamuave CA; García-Basteiro AL; Sanz A; Aldea M; Manoj A; Gunasekera A; Billingsley PF; Aponte JJ; James ER; Guinovart C; Antonijoan RM; Kremsner PG; Hoffman SL; Alonso PL Malar J; 2015 Aug; 14():306. PubMed ID: 26245196 [TBL] [Abstract][Full Text] [Related]
4. Safety and comparability of controlled human Plasmodium falciparum infection by mosquito bite in malaria-naïve subjects at a new facility for sporozoite challenge. Talley AK; Healy SA; Finney OC; Murphy SC; Kublin J; Salas CJ; Lundebjerg S; Gilbert P; Van Voorhis WC; Whisler J; Wang R; Ockenhouse CF; Heppner DG; Kappe SH; Duffy PE PLoS One; 2014; 9(11):e109654. PubMed ID: 25405724 [TBL] [Abstract][Full Text] [Related]
5. Reproducibility of malaria sporozoite challenge model in humans for evaluating efficacy of vaccines and drugs: a systematic review. Shibeshi W; Bagchus W; Yalkinoglu Ö; Tappert A; Engidawork E; Oeuvray C BMC Infect Dis; 2021 Dec; 21(1):1274. PubMed ID: 34930178 [TBL] [Abstract][Full Text] [Related]
6. Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of Jongo SA; Shekalaghe SA; Church LWP; Ruben AJ; Schindler T; Zenklusen I; Rutishauser T; Rothen J; Tumbo A; Mkindi C; Mpina M; Mtoro AT; Ishizuka AS; Kassim KR; Milando FA; Qassim M; Juma OA; Mwakasungula S; Simon B; James ER; Abebe Y; Kc N; Chakravarty S; Saverino E; Bakari BM; Billingsley PF; Seder RA; Daubenberger C; Sim BKL; Richie TL; Tanner M; Abdulla S; Hoffman SL Am J Trop Med Hyg; 2018 Aug; 99(2):338-349. PubMed ID: 29943719 [TBL] [Abstract][Full Text] [Related]
7. Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres. Mordmüller B; Supan C; Sim KL; Gómez-Pérez GP; Ospina Salazar CL; Held J; Bolte S; Esen M; Tschan S; Joanny F; Lamsfus Calle C; Löhr SJ; Lalremruata A; Gunasekera A; James ER; Billingsley PF; Richman A; Chakravarty S; Legarda A; Muñoz J; Antonijoan RM; Ballester MR; Hoffman SL; Alonso PL; Kremsner PG Malar J; 2015 Mar; 14():117. PubMed ID: 25889522 [TBL] [Abstract][Full Text] [Related]
8. Mosquito Infectivity and Parasitemia after Controlled Human Malaria Infection. Walk J; van Gemert GJ; Graumans W; Sauerwein RW; Bijker EM Am J Trop Med Hyg; 2018 Jun; 98(6):1705-1708. PubMed ID: 29714158 [TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial. Sissoko MS; Healy SA; Katile A; Zaidi I; Hu Z; Kamate B; Samake Y; Sissoko K; Mwakingwe-Omari A; Lane J; Imeru A; Mohan R; Thera I; Guindo CO; Dolo A; Niare K; Koïta F; Niangaly A; Rausch KM; Zeguime A; Guindo MA; Bah A; Abebe Y; James ER; Manoj A; Murshedkar T; Kc N; Sim BKL; Billingsley PF; Richie TL; Hoffman SL; Doumbo O; Duffy PE Lancet Infect Dis; 2022 Mar; 22(3):377-389. PubMed ID: 34801112 [TBL] [Abstract][Full Text] [Related]
11. Optimizing Intradermal Administration of Cryopreserved Plasmodium falciparum Sporozoites in Controlled Human Malaria Infection. Lyke KE; Laurens MB; Strauss K; Adams M; Billingsley PF; James E; Manoj A; Chakravarty S; Plowe CV; Li ML; Ruben A; Edelman R; Green M; Dube TJ; Sim BKL; Hoffman SL Am J Trop Med Hyg; 2015 Dec; 93(6):1274-1284. PubMed ID: 26416102 [TBL] [Abstract][Full Text] [Related]
12. Safety, Immunogenicity, and Protective Efficacy of Intradermal Immunization with Aseptic, Purified, Cryopreserved Plasmodium falciparum Sporozoites in Volunteers Under Chloroquine Prophylaxis: A Randomized Controlled Trial. Bastiaens GJH; van Meer MPA; Scholzen A; Obiero JM; Vatanshenassan M; van Grinsven T; Sim BKL; Billingsley PF; James ER; Gunasekera A; Bijker EM; van Gemert GJ; van de Vegte-Bolmer M; Graumans W; Hermsen CC; de Mast Q; van der Ven AJAM; Hoffman SL; Sauerwein RW Am J Trop Med Hyg; 2016 Mar; 94(3):663-673. PubMed ID: 26711509 [TBL] [Abstract][Full Text] [Related]
13. A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults. Sklar MJ; Maiolatesi S; Patterson N; Sedegah M; Limbach K; Teneza-Mora N; Chuang I; Hollis-Perry KM; Banania JG; Guzman I; Ganeshan H; Reyes S; Hollingdale MR; Wong M; Lindstrom A; Reyes A; Alcorta Y; Garver L; Bankard K; Belmonte A; Belmonte M; Huang J; Gowda K; Inoue S; Velasco R; Bergmann-Leitner E; Hutter J; Lee T; Adams N; Chaudhury S; Hunt D; Tamminga C; Berrie E; Bellamy D; Bittaye M; Ewer K; Diggs C; Soisson LA; Lawrie A; Hill A; Richie TL; Villasante E; Epstein JE; Duplessis CA PLoS One; 2021; 16(9):e0256980. PubMed ID: 34495988 [TBL] [Abstract][Full Text] [Related]